These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 22699885)
1. A systematic review and meta-analysis of Macroplastique for treating female stress urinary incontinence. Ghoniem GM; Miller CJ Int Urogynecol J; 2013 Jan; 24(1):27-36. PubMed ID: 22699885 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of polydimethylsiloxane injection (Macroplastique Serati M; Soligo M; Braga A; Cantaluppi S; Coluccia AC; Di Dedda MC; Salvatore S; Cetin I; Ghezzi F; BJU Int; 2019 Feb; 123(2):353-359. PubMed ID: 30253026 [TBL] [Abstract][Full Text] [Related]
3. Does the Polydimethylsiloxane Urethral Injection (Macroplastique Serati M; Braga A; Scancarello C; De Rosa A; Frigerio M; Baruch Y; Torella M; Salvatore S; Ruffolo AF Medicina (Kaunas); 2023 Mar; 59(3):. PubMed ID: 36984580 [No Abstract] [Full Text] [Related]
4. Macroplastique Is a Safe and Effective Long-term Surgical Treatment for Stress Urinary Incontinence: Prospective Study with 10-Year Follow-up. Serati M; Scancarello C; Mesiano G; Cimmino C; Campitiello MR; Salvatore S; Ghezzi F; Caccia G; Papadia A; Braga A Eur Urol Focus; 2024 Aug; ():. PubMed ID: 39095217 [TBL] [Abstract][Full Text] [Related]
5. Comparison between porcine dermal implant (Permacol) and silicone injection (Macroplastique) for urodynamic stress incontinence. Bano F; Barrington JW; Dyer R Int Urogynecol J Pelvic Floor Dysfunct; 2005; 16(2):147-50; discussion 150. PubMed ID: 15378234 [TBL] [Abstract][Full Text] [Related]
6. Cross-linked polydimethylsiloxane injection for female stress urinary incontinence: results of a multicenter, randomized, controlled, single-blind study. Ghoniem G; Corcos J; Comiter C; Bernhard P; Westney OL; Herschorn S J Urol; 2009 Jan; 181(1):204-10. PubMed ID: 19013613 [TBL] [Abstract][Full Text] [Related]
7. Urethral bulking agents for the treatment of stress urinary incontinence in women: A systematic review. Hoe V; Haller B; Yao HH; O'Connell HE Neurourol Urodyn; 2021 Aug; 40(6):1349-1388. PubMed ID: 34015151 [TBL] [Abstract][Full Text] [Related]
8. Intraurethral bulking agents for the management of female stress urinary incontinence: a systematic review. Siddiqui ZA; Abboudi H; Crawford R; Shah S Int Urogynecol J; 2017 Sep; 28(9):1275-1284. PubMed ID: 28220200 [TBL] [Abstract][Full Text] [Related]
10. Treatment of postoperative male urinary incontinence using transurethral macroplastique injections. Kylmälä T; Tainio H; Raitanen M; Tammela TL J Endourol; 2003 Mar; 17(2):113-5. PubMed ID: 12689406 [TBL] [Abstract][Full Text] [Related]
11. Durability of urethral bulking agent injection for female stress urinary incontinence: 2-year multicenter study results. Ghoniem G; Corcos J; Comiter C; Westney OL; Herschorn S J Urol; 2010 Apr; 183(4):1444-9. PubMed ID: 20171691 [TBL] [Abstract][Full Text] [Related]
12. Can Urethral Bulking Agents Salvage Failed Slings? Dray EV; Hall M; Covalschi D; Cameron AP Urology; 2019 Feb; 124():78-82. PubMed ID: 30412703 [TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of polydimethylsiloxane (Macroplastique®) in women with stress urinary incontinence: analysis of data from patients who completed three years follow-up. Ghoniem G; Farhan B; Chowdhury ML; Chen Y Int Urogynecol J; 2021 Oct; 32(10):2835-2840. PubMed ID: 34100973 [TBL] [Abstract][Full Text] [Related]
14. Outcomes of Macroplastique injections for stress urinary incontinence after suburethral sling removal. Rodríguez D; Carroll T; Alhalabi F; Carmel M; Zimmern PE Neurourol Urodyn; 2020 Mar; 39(3):994-1001. PubMed ID: 32068306 [TBL] [Abstract][Full Text] [Related]
15. Three-dimensional endovaginal ultrasound examination following injection of Macroplastique for stress urinary incontinence: outcomes based on location and periurethral distribution of the bulking agent. Hegde A; Smith AL; Aguilar VC; Davila GW Int Urogynecol J; 2013 Jul; 24(7):1151-9. PubMed ID: 23229417 [TBL] [Abstract][Full Text] [Related]
16. Results of an innovative bulking agent in patients with stress urinary incontinence who are not optimal candidates for mid-urethral sling surgery. Kowalik CR; Casteleijn FM; van Eijndhoven HWF; Zwolsman SE; Roovers JWR Neurourol Urodyn; 2018 Jan; 37(1):339-345. PubMed ID: 28452427 [TBL] [Abstract][Full Text] [Related]
17. Bladder neck and urethral erosions after Macroplastique injections. Rodríguez D; Jaffer A; Hilmy M; Zimmern P Low Urin Tract Symptoms; 2021 Jan; 13(1):93-97. PubMed ID: 32783393 [TBL] [Abstract][Full Text] [Related]
18. Clinical presentation and treatment of Macroplastique® urethral exposures: a retrospective case series. Ramirez-Caban L; Malekzadeh M; Ossin DA; Hurtado EA Int Urogynecol J; 2022 Mar; 33(3):681-687. PubMed ID: 34213601 [TBL] [Abstract][Full Text] [Related]
19. Bulking for stress urinary incontinence in men: A systematic review. Toia B; Gresty H; Pakzad M; Hamid R; Ockrim J; Greenwell T Neurourol Urodyn; 2019 Sep; 38(7):1804-1811. PubMed ID: 31321804 [TBL] [Abstract][Full Text] [Related]
20. The role of macroplastique implantation in the management of occult urinary stress incontinence. Montera R; Scaletta G; Plotti F; Lopez S; Luvero D; Capriglione S; Aloisi A; Gatti A; De Cicco Nardone C; Carassiti R; Terranova C; Angioli R Eur J Obstet Gynecol Reprod Biol; 2018 Jun; 225():124-128. PubMed ID: 29704816 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]